248 related articles for article (PubMed ID: 34852175)
1. Disease progression and clinical outcomes in telomere biology disorders.
Niewisch MR; Giri N; McReynolds LJ; Alsaggaf R; Bhala S; Alter BP; Savage SA
Blood; 2022 Mar; 139(12):1807-1819. PubMed ID: 34852175
[TBL] [Abstract][Full Text] [Related]
2. Progression of liver disease and portal hypertension in dyskeratosis congenita and related telomere biology disorders.
Vittal A; Niewisch MR; Bhala S; Kudaravalli P; Rahman F; Hercun J; Kleiner DE; Savage SA; Koh C; Heller T; Giri N
Hepatology; 2023 Dec; 78(6):1777-1787. PubMed ID: 37184208
[TBL] [Abstract][Full Text] [Related]
3. An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.
Niewisch MR; Savage SA
Expert Rev Hematol; 2019 Dec; 12(12):1037-1052. PubMed ID: 31478401
[No Abstract] [Full Text] [Related]
4. Dyskeratosis congenita and telomere biology disorders.
Savage SA
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):637-648. PubMed ID: 36485133
[TBL] [Abstract][Full Text] [Related]
5. Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita.
Choo S; Lorbeer FK; Regalado SG; Short SB; Wu S; Rieser G; Bertuch AA; Hockemeyer D
Blood; 2022 Aug; 140(6):608-618. PubMed ID: 35421215
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of pulmonary function tests in dyskeratosis congenita, a telomere biology disorder.
Giri N; Ravichandran S; Wang Y; Gadalla SM; Alter BP; Fontana J; Savage SA
ERJ Open Res; 2019 Oct; 5(4):. PubMed ID: 31754622
[TBL] [Abstract][Full Text] [Related]
7. Telomere biology disorders may manifest as common variable immunodeficiency (CVID).
Rolles B; Caballero-Oteyza A; Proietti M; Goldacker S; Warnatz K; Camacho-Ordonez N; Prader S; Schmid JP; Vieri M; Isfort S; Meyer R; Kirschner M; Brümmendorf TH; Beier F; Grimbacher B
Clin Immunol; 2023 Dec; 257():109837. PubMed ID: 37944684
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.
Agarwal S
Hematol Oncol Clin North Am; 2018 Aug; 32(4):669-685. PubMed ID: 30047419
[TBL] [Abstract][Full Text] [Related]
9. Telomere length is associated with disease severity and declines with age in dyskeratosis congenita.
Alter BP; Rosenberg PS; Giri N; Baerlocher GM; Lansdorp PM; Savage SA
Haematologica; 2012 Mar; 97(3):353-9. PubMed ID: 22058220
[TBL] [Abstract][Full Text] [Related]
10. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.
Walne AJ; Vulliamy T; Beswick R; Kirwan M; Dokal I
Blood; 2008 Nov; 112(9):3594-600. PubMed ID: 18669893
[TBL] [Abstract][Full Text] [Related]
11. Dyskeratosis congenita: telomerase, telomeres and anticipation.
Marrone A; Walne A; Dokal I
Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
[TBL] [Abstract][Full Text] [Related]
12. Treatment of telomeropathies.
Vieri M; Brümmendorf TH; Beier F
Best Pract Res Clin Haematol; 2021 Jun; 34(2):101282. PubMed ID: 34404536
[TBL] [Abstract][Full Text] [Related]
13. The molecular genetics of the telomere biology disorders.
Bertuch AA
RNA Biol; 2016 Aug; 13(8):696-706. PubMed ID: 26400640
[TBL] [Abstract][Full Text] [Related]
14. The distribution and accumulation of the shortest telomeres in telomere biology disorders.
Raj HA; Lai TP; Niewisch MR; Giri N; Wang Y; Spellman SR; Aviv A; Gadalla SM; Savage SA
Br J Haematol; 2023 Dec; 203(5):820-828. PubMed ID: 37354000
[TBL] [Abstract][Full Text] [Related]
15. The genetics and clinical manifestations of telomere biology disorders.
Savage SA; Bertuch AA
Genet Med; 2010 Dec; 12(12):753-64. PubMed ID: 21189492
[TBL] [Abstract][Full Text] [Related]
16. Human telomeres and telomere biology disorders.
Savage SA
Prog Mol Biol Transl Sci; 2014; 125():41-66. PubMed ID: 24993697
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders.
Balakumaran A; Mishra PJ; Pawelczyk E; Yoshizawa S; Sworder BJ; Cherman N; Kuznetsov SA; Bianco P; Giri N; Savage SA; Merlino G; Dumitriu B; Dunbar CE; Young NS; Alter BP; Robey PG
Blood; 2015 Jan; 125(5):793-802. PubMed ID: 25499762
[TBL] [Abstract][Full Text] [Related]
18. Dyskeratosis congenita -- a disease of dysfunctional telomere maintenance.
Mason PJ; Wilson DB; Bessler M
Curr Mol Med; 2005 Mar; 5(2):159-70. PubMed ID: 15974869
[TBL] [Abstract][Full Text] [Related]
19. The biology and management of dyskeratosis congenita and related disorders of telomeres.
Tummala H; Walne A; Dokal I
Expert Rev Hematol; 2022 Aug; 15(8):685-696. PubMed ID: 35929966
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
